Trading Halt
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Microba Life Sciences Limited has requested a trading halt from the ASX pending an announcement regarding a proposed capital raise. The halt will remain in effect until normal trading resumes or the announcement is made, whichever comes first. The company has confirmed that it is not aware of any reasons why the trading halt should not be granted.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/trading-halt-670
Microba Life Sciences Limited on 6ix
Earlier from Microba Life Sciences
- MetaPanel Pathogen Study Delivers Breakthrough Results
- Microba Announces Landmark GI Study Results From Over 4,600 Patients
- Landmark GI Study Results from over 4,600 patients
- Q3 FY25 Quarterly Investor Presentation & Webinar
- Q3 FY25 Quarterly Activities Report & Appendix 4C
Later from Microba Life Sciences
- Suspension from Quotation
- Microba secures $14.5 million to drive clinical adoption
- Reinstatement to Quotation
- Strategic Investment & Equity Raise Presentation
- Disclosure Document - Prospectus
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences